当前位置: 首页 >> 检索结果
2681. Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups : A Systematic Review and Individual-Patient Data Meta-analysis.
作者: Milou A M Stals.;Toshihiko Takada.;Noémie Kraaijpoel.;Nick van Es.;Harry R Büller.;D Mark Courtney.;Yonathan Freund.;Javier Galipienzo.;Grégoire Le Gal.;Waleed Ghanima.;Menno V Huisman.;Jeffrey A Kline.;Karel G M Moons.;Sameer Parpia.;Arnaud Perrier.;Marc Righini.;Helia Robert-Ebadi.;Pierre-Marie Roy.;Maarten van Smeden.;Phil S Wells.;Kerstin de Wit.;Geert-Jan Geersing.;Frederikus A Klok.
来源: Ann Intern Med. 2022年175卷2期244-255页
How diagnostic strategies for suspected pulmonary embolism (PE) perform in relevant patient subgroups defined by sex, age, cancer, and previous venous thromboembolism (VTE) is unknown.
2682. SARS-CoV-2 Vaccine Antibody Response and Breakthrough Infection in Patients Receiving Dialysis.
作者: Shuchi Anand.;Maria E Montez-Rath.;Jialin Han.;Pablo Garcia.;LinaCel Cadden.;Patti Hunsader.;Curt Morgan.;Russell Kerschmann.;Paul Beyer.;Mary Dittrich.;Geoffrey A Block.;Glenn M Chertow.;Julie Parsonnet.
来源: Ann Intern Med. 2022年175卷3期371-378页
Whether breakthrough SARS-CoV-2 infections after vaccination are related to the level of postvaccine circulating antibody is unclear.
2683. In suspected ACS, an unmasked 0/1-h vs. masked 0/3-h hs-cTnT protocol did not differ for death or MI at 1 y.
Lambrakis K, Papendick C, French JK, et al. Late outcomes of the RAPID-TnT randomized controlled trial: 0/1-hour high-sensitivity troponin T protocol in suspected ACS. Circulation. 2021;144:113-25. 33998255.
2684. In ACS, de-escalation of DAPT reduces bleeding and does not increase ischemic events vs. other DAPT strategies.
Shoji S, Kuno T, Fujisaki T, et al. De-escalation of dual antiplatelet therapy in patients with acute coronary syndromes. J Am Coll Cardiol. 2021;78:763-77. 34275697.
2687. Thiamine Supplementation in Patients With Alcohol Use Disorder Presenting With Acute Critical Illness : A Nationwide Retrospective Observational Study.
作者: Rahul D Pawar.;Lakshman Balaji.;Anne V Grossestreuer.;Garrett Thompson.;Mathias J Holmberg.;Mahmoud S Issa.;Parth V Patel.;Ryan Kronen.;Katherine M Berg.;Ari Moskowitz.;Michael W Donnino.
来源: Ann Intern Med. 2022年175卷2期191-197页
Thiamine supplementation is recommended for patients with alcohol use disorder (AUD). The authors hypothesize that critically ill patients with AUD are commonly not given thiamine supplementation.
2688. Video Teleconferencing for Disease Prevention, Diagnosis, and Treatment : A Rapid Review.
作者: Jordan Albritton.;Alexa Ortiz.;Roberta Wines.;Graham Booth.;Michael DiBello.;Stephen Brown.;Gerald Gartlehner.;Karen Crotty.
来源: Ann Intern Med. 2022年175卷2期256-266页
Video teleconferencing (VTC) as a substitute for in-person health care or as an adjunct to usual care has increased in recent years.
2689. In paroxysmal AF, first-line catheter ablation vs. antiarrhythmic drugs reduces atrial arrhythmia recurrence.
Imberti JF, Ding WY, Kotalczyk A, et al. Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis. Heart. 2021;107:1630-6. 34261737.
2690. In critically ill patients with COVID-19, therapeutic anticoagulation did not increase organ support-free days.
Goligher EC, Bradbury CA, McVerry BJ, et al. Therapeutic anticoagulation with heparin in critically ill patients with Covid-19. N Engl J Med. 2021;385:777-89. 34351722.
2691. In non-critically ill patients with COVID-19, therapeutic anticoagulation improved survival to discharge without organ support.
Lawler PR, Goligher EC, Berger JS, et al. Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19. N Engl J Med. 2021;385:790-802. 34351721.
2692. In rotator cuff disorder, progressive exercise vs. physiotherapy advice, with or without corticosteroid injection, did not differ at 12 mo.
Hopewell S, Keene DJ, Marian IR, et al. Progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of patients with rotator cuff disorders (GRASP): a multicentre, pragmatic, 2 x 2 factorial, randomised controlled trial. Lancet. 2021;398:416-28. 34265255.
2693. Comparison of a Hemostatic Powder and Standard Treatment in the Control of Active Bleeding From Upper Nonvariceal Lesions : A Multicenter, Noninferiority, Randomized Trial.
作者: James Y W Lau.;Rapat Pittayanon.;Andrew Kwek.;Raymond S Tang.;Heyson Chan.;Rungsun Rerknimitr.;June Lee.;Tiing Leong Ang.;Bing-Yee Suen.;Yuan-Yuan Yu.;Francis K L Chan.;Joseph J Y Sung.
来源: Ann Intern Med. 2022年175卷2期171-178页
The effectiveness of the hemostatic powder TC-325 as a single endoscopic treatment for acute nonvariceal upper gastrointestinal bleeding is uncertain.
2694. WHO provides 2 conditional recommendations for casirivimab-imdevimab combination therapy in COVID-19.
Rochwerg B, Agarwal A, Siemieniuk RA, et al. Update to living WHO guideline on drugs for covid-19. BMJ. 2021;374:n2219. 34556469.
2695. Post-TKA abelacimab reduced VTE at 8 to 12 d compared with enoxaparin.
Verhamme P, Yi BA, Segers A, et al. Abelacimab for prevention of venous thromboembolism. N Engl J Med. 2021;385:609-17. 34297496.
2696. Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data.
作者: Ghadeer K Dawwas.;Charles E Leonard.;James D Lewis.;Adam Cuker.
来源: Ann Intern Med. 2022年175卷1期20-28页
Apixaban and rivaroxaban are replacing vitamin K antagonists for the treatment of venous thromboembolism (VTE) in adults; however, head-to-head comparisons remain limited.
2697. Patients with COVID-19 had increased risk for acute MI and ischemic stroke at 14 d vs. matched controls.
Katsoularis I, Fonseca-Rodriguez O, Farrington P, et al. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet. 2021;398:599-607. 34332652.
2698. In afebrile men with UTIs, 7 d of ciprofloxacin or trimethoprim-sulfamethoxazole was noninferior to 14 d.
Drekonja DM, Trautner B, Amundson C, et al. Effect of 7 vs 14 days of antibiotic therapy on resolution of symptoms among afebrile men with urinary tract infection: a randomized clinical trial. JAMA. 2021;326:324-31. 34313686.
2699. PRIORITY risk model predicted critical outcomes in patients hospitalized with COVID-19.
Martínez-Lacalzada M, Viteri-Noël A, Manzano L, et al. Predicting critical illness on initial diagnosis of COVID-19 based on easily-obtained clinical variables: development and validation of the PRIORITY model. Clin Microbiol Infect. 2021. [Epub ahead of print]. 34274525.
|